A Prospective Trial Comparing Haploidentical Donor Transplantation With Cord Blood Versus HLA-Matched Sibling Donor Transplantation for Hematologic Malignancy Patients

Wenyi Lu; Xin Jin; Hairong Lyu; Xue Bai; Haibo Zhu; Xin Li; Xia Xiao; Juanxia Meng; Ting Yuan; Qing Li; Juan Mu; Cuicui Lyu; Yili Jiang; Yunxiong Wei; Xia Xiong; Meng Zhang; Mingfeng Zhao

doi:10.1177/09636897221076050

A Prospective Trial Comparing Haploidentical Donor Transplantation With Cord Blood Versus HLA-Matched Sibling Donor Transplantation for Hematologic Malignancy Patients

Cell Transplant. 2022 Jan-Dec:31:9636897221076050. doi: 10.1177/09636897221076050.

Authors

Wenyi Lu^{1

2}, Xin Jin³, Hairong Lyu^{1

2}, Xue Bai^{1

2}, Haibo Zhu^{1

2}, Xin Li^{1

2}, Xia Xiao^{1

2}, Juanxia Meng^{1

2}, Ting Yuan^{1

2}, Qing Li^{1

2}, Juan Mu^{1

2}, Cuicui Lyu^{1

2}, Yili Jiang^{1

2}, Yunxiong Wei¹, Xia Xiong¹, Meng Zhang¹, Mingfeng Zhao^{1

2}

Affiliations

¹ Department of Hematology, Tianjin First Central Hospital, Tianjin, PR China.
² Nankai University Affiliated First Central Hospital, Tianjin, PR China.
³ School of Medicine, Nankai University, Tianjin, PR China.

Abstract

Effect of co-infusion third party umbilical cord blood stem cells on haploidentical hematopoietic stem cell transplantation https://www.chictr.org.cn Reg. No. ChiCTR-OIN-17011426.

Keywords: HLA-identical sibling donor; cord blood; graft-versus-host disease; haploidentical donor; hematopoietic stem cell transplantation.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Fetal Blood
Graft vs Host Disease*
Hematologic Neoplasms* / therapy
Hematopoietic Stem Cell Transplantation*
Humans
Prospective Studies
Siblings